News

Strong Business Performance Lifted RB Global (RBA) in Q1
Meridian Funds, managed by ArrowMark Partners, released its “Meridian Growth Fund” first quarter 2025 investor letter.
Meridian Growth Fund Trimmed Halozyme Therapeutics (HALO) for the Valuation Discipline
Meridian Funds, managed by ArrowMark Partners, released its “Meridian Growth Fund” first quarter 2025 investor letter.
What Makes Permian Resources Corporation (PR) an Investment Bet?
Artisan Partners, an investment management company, released its “Artisan Mid Cap Value Fund” first-quarter 2025 investor ...
Here’s Why Bio-Rad Laboratories (BIO) Traded Lower in Q1
Artisan Partners, an investment management company, released its “Artisan Mid Cap Value Fund” first-quarter 2025 investor ...
Polaris (PII) Declined on Weak Demand
Artisan Partners, an investment management company, released its “Artisan Mid Cap Value Fund” first-quarter 2025 investor ...
DA Davidson Raises Citi Trends (CTRN) PT to $40, Cites Growth from Closeout Product Strategy
DA Davidson increased its price target on Citi Trends Inc. (NASDAQ:CTRN) to $40 from $29, while maintaining a Buy rating on ...
Does Genpact (G) Have a Long Runway for Growth?
Artisan Partners, an investment management company, released its “Artisan Mid Cap Value Fund” first-quarter 2025 investor ...
Itau BBA Upgrades El Puerto de Liverpool (ELPQF) to Outperform, Sets PT at MXN 195
On Wednesday, El Puerto de Liverpool (OTC: ELPQF) received an upgrade from Itau BBA. The firm upgraded El Puerto’s rating ...
Baxter International (BAX) Rebounded in Q1 After Reporting Strong Earnings
Artisan Partners, an investment management company, released its “Artisan Mid Cap Value Fund” first-quarter 2025 investor ...
How will CME Group (CME) Benefit from the Tariffs?
Appalaches Capital, an investment management firm, released its first quarter 2025 investor letter. A copy of the letter can ...
Immix Biopharma’s NXC-201 Achieves 70% Complete Response Rate in AL Amyloidosis Trial
The interim data, with a cutoff date of April 11, 2025, showed an impressive 70% CR rate. Prior to NXC-201 treatment, the ...
Wells Fargo Raises McKesson (MCK) Price Target, Maintains Equal Weight Rating
Wells Fargo raised its price target on McKesson Corporation (NYSE:MCK) to $766 from $691, on June 3, while maintaining an ...